期刊文献+

阿托伐他汀对高血压患者肾损害的影响 被引量:3

下载PDF
导出
摘要 目的探讨阿托伐他汀对高血压患者肾损害的影响。方法选取血压控制达标的高血压并微量白蛋白尿患者100例,随机分为治疗组和对照组,治疗组予以阿托伐他汀20 mg/d,对照组加用安慰剂治疗,两组治疗前及治疗后12周采用速率散射比浊法检测尿微量白蛋白(mAlb)、β_2-微球蛋白(β_2-MG),全定量酶免疫法测定尿视黄醇结合蛋白(RBP),速率法检测N-乙酰-β-D氨基葡萄糖苷酶(NAG),Jaffe速率法测定尿肌酐。结果治疗组患者RBP、mAlb、β_2-MG、NAG均较治疗前和对照组治疗后显著下降,差异均有统计学意义(P<0.01),无严重不良反应。结论阿托伐他汀能减轻高血压患者肾损害及改善肾功能。
作者 叶梅
出处 《中国医学创新》 CAS 2011年第27期60-61,共2页 Medical Innovation of China
  • 引文网络
  • 相关文献

参考文献3

二级参考文献24

  • 1乔玉峰,庞东梓,张志利,蒋云生.糖尿病肾病早期诊断指标研究进展[J].国外医学(泌尿系统分册),2005,25(5):670-673. 被引量:13
  • 2Parving HH, Andersen AR, Smibt UM, et al. Effect of antihypertensive treatment on kidney function in diabetic nephropathy [J]. Br Med J, 1987,294: 1443-1447.
  • 3Hong CY, Chia KS. Markers of diabetic nephropathy[J]. J Diabetes Complications, 1998,12:43-60.
  • 4Albert CMO, Leon GF. Loss of glomerular function and tubulointerstitial fibrosis : cause or effect [J]. Kidney Internationall, 1994,45:345-351.
  • 5Bosin E, Monji N. Analysis of retinol-binding protein in serum and urine [J]. Clin Biochem, 1987,20 : 47-51.
  • 6Yu H, Yanagisawn Y, Forbes MA, et al. Alpha-1-Microglobulin : an indicator protein for renal tubular function[J]. J Chin Pathol, 1983,36:253-259.
  • 7Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function-a review. Clin Chem Lab Med, 1999,37:389-395.
  • 8Dharnidharka VR,Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function : a meta-analysis.Am J Kidney Dis,2002,40:221-226.
  • 9National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.Am J Kidney Dis,2002,39(2 Suppl 1 ) :S1-266.
  • 10Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine : a new prediction equation. Ann Intem Med, 1999,130:461-470.

共引文献234

同被引文献31

引证文献3

二级引证文献7

相关主题

;
使用帮助 返回顶部